BioMarin Pharmaceutical Inc.BMRNNASDAQ
Loading
Stockholders Equity Over TimeStrong
Percentile Rank100
3Y CAGR+9.8%
5Y CAGR+8.2%
Studio
Year-over-Year Change

Net worth of the company (assets minus liabilities)

3Y CAGR
+9.8%/yr
vs +11.6%/yr prior
5Y CAGR
+8.2%/yr
Consistent
Acceleration
-1.8pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.5x
Solid growth
Streak
9 yr
Consecutive growthStrong
PeriodValueYoY Change
2025$6.09B+7.6%
2024$5.66B+14.3%
2023$4.95B+7.6%
2022$4.60B+7.9%
2021$4.27B+3.9%
2020$4.11B+31.5%
2019$3.12B+5.2%
2018$2.97B+5.7%
2017$2.81B+1.5%
2016$2.77B-